Gempharmatech Co. Ltd. A Financial Flexibility Index
Gempharmatech Co. Ltd. A financial flexibility index. Gempharmatech Co. Ltd. A (688046) has a Financial Flexibility Index of 0.47x as of December 2024. Free cash flow of CN¥203.99 Million (operating CF CN¥90.31 Million minus capex CN¥113.68 Million) represents 0% of total liabilities (CN¥437.92 Million). Explore 688046 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Gempharmatech Co. Ltd. A (2019–2024)
Financial flexibility index of Gempharmatech Co. Ltd. A from 2019 to 2024. Historical Financial Flexibility Index trend for Gempharmatech Co. Ltd. A across 6 annual periods. Check cash flow reinvestment rate of Gempharmatech Co. Ltd. A to assess the company's total reinvestment commitment from operating cash flow.
Gempharmatech Co. Ltd. A Financial Flexibility Index by Year (2019–2024)
Gempharmatech Co. Ltd. A financial flexibility index by year from 2019 to 2024. Year-by-year free cash flow to debt coverage for Gempharmatech Co. Ltd. A. For the full cash flow conversion analysis, see Gempharmatech Co. Ltd. A operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.47x | CN¥203.99 Million | CN¥90.31 Million | CN¥437.92 Million | ▼ -34.6% |
| 2023 | 0.71x | CN¥322.47 Million | CN¥116.57 Million | CN¥452.93 Million | ▼ -33.7% |
| 2022 | 1.07x | CN¥296.29 Million | CN¥105.98 Million | CN¥276.00 Million | ▲ +42.6% |
| 2021 | 0.75x | CN¥202.39 Million | CN¥113.31 Million | CN¥268.78 Million | ▼ -42.7% |
| 2020 | 1.31x | CN¥296.85 Million | CN¥129.79 Million | CN¥225.95 Million | ▲ +75.1% |
| 2019 | 0.75x | CN¥110.78 Million | CN¥65.12 Million | CN¥147.66 Million | — |